Catalyst Wire Dossier Catalyst Wire Dossier

Glucosamine/Chondroitin Sulfate

glucosamine; chondroitin sulfate · Eurofarma Laboratorios S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glucosamine/Chondroitin Sulfate, covering 2023-02-08 to 2023-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee [Phase 3]

See pricing